As drug coverage increases as a result of expanded health insurance and Medicaid coverage under the USA’s Affordable Care Act, unnecessary regulations will increase prescription drug costs, according to a new study from the National Center for Policy Analysis (NCPA).
"Sixty percent of all Americans take a prescription drug in any given year, and nearly all seniors do," said NCPA Senior Fellow Devon Herrick, adding: "Drug coverage is expanding rapidly and heightened regulatory scrutiny will prevent drug plans managers from holding down costs for consumers with programs such as creating exclusive networks and encouraging mail-order prescriptions."
Mr Herrick said there are many barriers, regulations and practices that restrict competitive bidding among drug plan stakeholders, noting the following:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze